EVALUATION OF THE EFFICACY AND SAFETY OF A GLYCOSAMINOGLYCAN-PEPTIDE COMPLEX IN THE TREATMENT OF KNEE OSTEOARTHRITIS IN PATIENTS WITH PREVIOUS INEFFICIENCY OF SLOW-RELEASE ORAL ANTI-INFLAMMATORY DRUGS (THE MULTICENTER OPEN-LABEL STUDY PRIMULA: USE OF RUMALON® WITH INITIALLY SMALL SUCCESS IN THE TREATMENT OF OSTEOARTHRITIS)

Glycosaminoglycan-peptide complex (GPC) (Rumalon®) is an injectable slow-release anti-inflammatory agent (SRIA) that has complex anti-inflammatory and metabolic effects. GPC has been successfully used in the treatment of osteoarthritis (OA) for several decades. The agent now returns again to Russian...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: A. E. Karateev, L. I. Alekseeva, A. M. Lila, S. A. Makarov, N. V. Chichasova, E. V. Zonova, N. G. Kashevarova, E. A. Taskina, E. P. Sharapova
Formato: Artigo
Idioma:Russo
Publicado em: IMA-PRESS LLC 2018-03-01
Colecção:Научно-практическая ревматология
Assuntos:
osteoarthritis
glycosaminoglycan-peptide complex
efficacy
safety
Acesso em linha:https://rsp.mediar-press.net/rsp/article/view/2495
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados